NCT02675829 2026-03-04Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant CancersMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting131 enrolled
NCT04579380 2025-12-19Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 AlterationsSeagen Inc.Phase 2 Active not recruiting217 enrolled 19 charts